超声引导下经皮穿刺肺活检假阴性结果预测模型的构建与验证
本研究基于两个前瞻性队列构建并验证超声引导下经皮穿刺肺活检假阴性风险预测模型。模型纳入年龄、病灶大小、弹性评分、病灶坏死及超声造影增强强度,建模集129例中假阴性35例(29.1%),AUC为0.922、敏感度88.6%、特异度90.4%。在423例中应用模型并对高危患者行二次活检,假阴性发生率显著降低。
要点
- 模型纳入年龄、病灶大小、弹性评分、坏死及超声造影增强强度共5项预测因子。
- 建模集假阴性率29.1%(35/129),模型AUC 0.922、敏感度88.6%、特异度90.4%。
- 对高危患者行二次活检后,假阴性发生率显著降低。
核心结论
- 该模型结合临床参数与多模态超声特征,可作为术后客观评估超声引导下经皮穿刺肺活检假阴性风险的稳健工具。
- 临床应用可实现早期风险分层、降低假阴性率并提高诊断准确性。
研究设计与样本
- 研究设计为两个前瞻性队列,分别用于模型开发与验证。
- 建模集129例,验证集70例(独立收集),应用集423例。
- 患者行B型超声、彩色多普勒血流成像、超声弹性成像及超声造影检查,最终诊断经综合评估确认。
- 采用多因素logistic回归构建预测模型。
关键影像表现/征象
- 预测因子包括年龄、病灶大小、弹性评分、病灶坏死及超声造影增强强度。
诊断标准与关键数值
- 建模集129例中35例(29.1%)最终诊断为假阴性结果。
- 模型AUC为0.922,敏感度88.6%,特异度90.4%。
- 内部验证在70例独立收集患者中证实模型性能稳健。
临床应用与阅片要点
- 模型可作为术后工具客观评估假阴性风险,辅助早期风险分层。
- 对高危患者行二次活检,在423例中应用后假阴性发生率显著降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to develop a post-procedural predictive model for assessing the risk of false-negative results in ultrasound-guided percutaneous transthoracic needle lung biopsy (US-PTLB).
MATERIAL AND METHODS: Two prospective cohorts were designed for model development and validation. Patients scheduled for US-PTLB underwent B-mode ultrasound (B-US), color Doppler flow imaging (CDFI), ultrasound elastography, and contrast-enhanced ultrasound (CEUS) of the lesions, with the final diagnosis confirmed through comprehensive evaluation. Risk factors associated with false-negative results were identified, and multivariate logistic regression was used to construct the predictive model. The model's performance was further evaluated in an independent cohort to assess its impact on reducing the incidence of false-negative results through targeted interventions.
RESULTS: The US-PTLB false-negative risk prediction model was constructed using data from 129 patients, of whom 35 (29.1%) were ultimately diagnosed with false-negative results. Predictors included age, lesion size, elasticity score, lesion necrosis, and enhancement intensity on CEUS. The model demonstrated excellent discrimination, with an area under the curve of 0.922, sensitivity of 88.6%, and specificity of 90.4%. Internal validation in 70 independently collected patients confirmed robust model performance. Application of the model in 423 patients, coupled with second biopsies for high-risk patients, led to a significant reduction in the incidence of false-negative results.
CONCLUSION: This predictive model, combining clinical parameters with multimodal ultrasound features, serves as a robust post-procedural tool for objectively assessing false-negative risk in ultrasound-guided percutaneous transthoracic needle lung biopsy. Its clinical application enables early risk stratification, minimizes false-negative rates, and enhances diagnostic precision.
引用
- Yi J, Bi K, Shen M, et al. A Predictive Model for False-Negative Results in Ultrasound-Guided Percutaneous Transthoracic Needle Lung Biopsy. Acad Radiol. 2025. PMID: 41198525. doi:10.1016/j.acra.2025.10.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。